Formulation and Evaluation of Nelfinavir Extended Release Trilayer Matrix Tablets by Design of Experiment
DOI:
https://doi.org/10.37285/ijpsn.2018.11.5.6Abstract
The present study was aimed to develop once-daily controlled release trilayer matrix tablets of nelfinavir to achieve zero-order drug release for sustained plasma concentration. Nelfinavir trilayer matrix tablets were prepared by direct compression method and consisted of middle active layer with different grades of hydroxypropyl methylcellulose (HPMC), PVP (Polyvinyl Pyrrolidine) K-30 and MCC (Micro Crystalline Cellulose). Barrier layers were prepared with Polyox WSR-303, Xanthan gum, microcrystalline cellulose and magnesium stearate. Based on the evaluation parameters, drug dissolution profile and release drug kinetics DF8 were found to be optimized formulation. The developed drug delivery system provided prolonged drug release rates over a period of 24 h. The release profile of the optimized formulation (DF8) was described by the zero-order and best fitted to Higuchi model. FT-IR studies confirmed that there were no chemical interactions between drug and excipients used in the formulation. These results indicate that the approach used could lead to a successful development of a controlled release formulation of nelfinavir in the management of AIDS.
Downloads
Metrics
Keywords:
Nelfinavir, HPMC, Polyox WSR-303, Xanthan gum, Geomatrix Technology
Downloads
Published
How to Cite
Issue
Section
References
Colombo P, Conte U, Gazzaniga A, Maggi L, Sangalli M. E and Peppas N (1990). Drug release modulation by physical restrictions of matrix swelling. Int J Pharm 63: 43-48.
Conte U, Maggi L, Colombo P and La Manna A (1993). Multi-layered hydrophilic matrices as constant release devices. J Control Rel 26: 39-47.
Derakhshandeh K and Soleymani M (2010). Formulation and in vitro evaluation of nifedipine controlled release tablet: Influence of combination of hydrophilic and hydrophobic matrix forms. Asian J Pharmaceutics 4(4): 185-93.
Hong Wen and Kinam Park (2010). Oral controlled release formulation design and drug delivery. Theory to practice edited by Wiley publication, New Jersey 294-95.
Gohel MC, Parikh RK, Padshala MN, Sarvaiya KG and Jena DG (2007). Formulation and optimization of directly compressible isoniazid modified release matrix tablet. Ind J Pharm Sci, 69(5): 640-645.
Jalpar R and Patel Bhavik A (2011). Formulation and evaluation of oral controlled drug delivery system for a model anti diabetic drug Metformin. Int J Curr Pharma Res 3(2): 37-39.
Potturi PV and Sudhakar Y (2015). Formulation and in vitro/ in vivo evaluation of controlled release Entacapone trilayer matrix tablets by geomatrix. Int J Drug Delivery 7: 155-166.
Sinko P.J (2007). Martin’s Physical Pharmacy and Pharmaceutical Sciences. Published by Wolters Kluwer Health Pvt. Ltd, New Delhi 5: 553-559.
Talukdar MM, Mooter VD, Augustijns P, Maga TT, Verbeke N and Kinget R (1998). In vitro evaluation of xanthan gum as potential excipients for oral controlled release matrix tablet formulation. Int J Pharm 169: 105-13.
Talukdar MM and Vercammen JP (1993). Evaluation of xanthan gum as a hydrophilic matrix for controlled release dosage forms. Drug Dev Ind Pharm 19:1037-46.
Tobyn MJ, Stani forth JN and Baichwal AR (1996). Prediction of physical properties of a novel polysaccharide-controlled release system. Int J Pharm 128: 113-224.
Wadher KJ, Kakde RB and Umekar M (2011). Formulation of sustained release metformin hydrochloride matrix tablets: Influence of hydrophilic polymers on the release rate and in vitro evaluation. Inter J Res Control Rel 1(1): 9-16.
Yihong Q, Chidambaram N and Kolette F (1998). Design and evaluation of layered diffusional matrices for zero order sustained-release tablets. J Control Rel 51: 123-130.
